CHILD HEALTH IMPRINTS (CHIL) PTE. LTD. Business Review
Generally trustworthy, but minor verification is advised.
Company Overview
TrustScore
CHILD HEALTH IMPRINTS (CHIL) PTE. LTD.
UEN:201842071W
Review This Business
Recent transacted with CHILD HEALTH IMPRINTS (CHIL) PTE. LTD.?
How would you rate your overall satisfaction?
Be a part of the community and help others make informed decisions by sharing your experience. Your feedback not only helps the business improve but also assists other customers in choosing the best services and products available.
TrustScore Analysis
CHILD HEALTH IMPRINTS (CHIL) PTE. LTD. has a TrustScore of 80. Businesses in this range are generally considered reliable. However, it's still advisable to conduct reasonable checks before engaging in transactions.
Our preliminary analysis has revealed key insights about CHILD HEALTH IMPRINTS (CHIL) PTE. LTD.'s performance and market presence. Here‘s a summary of our findings:
Positive highlights
Has been operational for several years
Official business profile found on major search engines
Negative highlights
- No employer brand presence on career platforms
- Does not have accessible contact information online
Own this Business?
CHILD HEALTH IMPRINTS (CHIL) PTE. LTD.'s Business Reviews
No reviews available
Corporate Information for CHILD HEALTH IMPRINTS (CHIL) PTE. LTD.
Contact Information for CHILD HEALTH IMPRINTS (CHIL) PTE. LTD.
Associated News for CHILD HEALTH IMPRINTS (CHIL) PTE. LTD.
Neonatal care firm Child Health Imprints secures $3.26m funding
They plan to expand their manufacturing base in South Korea. Child Health Imprints (CHIL), a Singapore-based neonatal-clinical care improvement firm, has raised $3.26m (US$2.3m) in Pre-Series A funding led by HealthXCapital, with participation from Enterprise SG and other HNIs. CHIL aims to improve clinical outcomes in Neonatal ICUs using IoT system and digitization. The company develops and applies informational and computational technologies including IoT, artificial intelligence (AI), and predictive analysis to improve the early diagnosis of critical diseases and overall quality of neonatal intensive care units across the world.
Singapore's HealthXCapital leads $2.3m funding in Child Health Imprints
Singapore-based neonatal-clinical solutions startup Child Health Imprints (CHIL) has raised $2.4 million in its pre-Series A funding round led by healthcare investor HealthXCapital, according to an announcement. CHIL said the fresh capital raised in the funding round, which was also backed by Enterprise SG and high net worth individuals, will go towards expanding its integrated neonatal ICU (NICU) care services in Asia Pacific as well as in securing international regulatory approvals. The healthcare startup said it develops proprietary NICU solutions to provide real-time data and analytics to clinicians so they can easily monitor and treat newborn babies who are at risk.
Neonatal tech startup Child Health Imprints raises US$2.3m in pre-Series A round
CHILD Health Imprints (CHIL), a Singapore-based technology company focusing on neonatal clinical care, on Thursday announced it has raised US$2.3 million in pre-Series A funding. The round was led by Asian early-stage venture capital fund HealthXCapital which focuses on healthcare tech investments in South and South-east Asia. Other participants included Enterprise Singapore’s investment arm Seeds Capital, as well as high net worth individuals. CHIL aims to improve clinical outcomes in neonatal intensive care units (NICUs) by helping clinicians monitor and treat at-risk newborn babies. Its proprietary solutions aggregate in real-time the infants’ vital data, bedside clinical observations and laboratory results, and then analyse the data in medically comprehensive formats.
Company Industry
Singapore Standard Industrial Classification (SSIC)
32501
MANUFACTURE OF MEDICAL RESEARCH AND CLINICAL DIAGNOSTIC INSTRUMENTS AND SUPPLIES (EG REAGENTS)
RESEARCH AND EXPERIMENTAL DEVELOPMENT ON MEDICAL SCIENCE